NCT00056524

Data

{
  "briefSummary": "The purpose of this study is to evaluate the long-term safety of AVP-923 in the treatment of Involuntary Emotional Expression Disorder (IEED) also known as Pseudobulbar Affect (episodes of uncontrolled crying and/or laughter).",
  "completionDate": "2007-06",
  "conditions": [
    "Alzheimer's Disease",
    "Stroke",
    "Parkinson's Disease",
    "Traumatic Brain Injury"
  ],
  "enrollmentCount": 600,
  "enrollmentType": "ESTIMATED",
  "nctId": "NCT00056524",
  "phase": "PHASE3",
  "sponsorId": "avanir-pharmaceuticals",
  "startDate": "2003-02",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.",
  "url": "https://clinicaltrials.gov/study/NCT00056524"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version